Health Affairs · 2016 · 16 citations · 4 references
PharmacyPharmaceutical PolicyPharmacoeconomicsAmbulatory Care PharmacyPharmaceutical CareResource Utilization AnalysisOut-of-pocket SpendingPharmaceutical EconomicsPharmaceutical FinancingPrescription Drug CoveragePrescription Drug PolicySpecialty Drug CoverageOut-of-pocket Drug SpendingOut-of-pocket Prescription CostsPatient Out-of-pocket SpendingPrescription Drug CostsPrescription Drug ExpendituresPrescription Drug SpendingSpecialty Drug CostsSpecialty Drug Utilization
From 2003 to 2014 the proportion of specialty prescription drugs (defined as those reimbursed at $600 or more per thirty-day fill) nearly quadrupled. Over this time period, fills for specialty drugs increased by 198 percent and spending for the drugs increased by 292 percent, as percentages of total drug fills and spending. Median out-of-pocket spending increased by 46 percent for specialty drugs and decreased by 57 percent for nonspecialty drugs during this time.
4
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
John A. Romley, Dana P. Goldman, Michael Eber et al. · PubMed · 2012 · 30 citations